Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts in the eye's retina. The findings in animals may help advance treatment options for dry age-related macular degeneration.
In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier.
Four teams have won a prize competition aimed at integrating eye care and ocular imaging data into studies using large healthcare datasets in biomedical research.
Scientists at the National Institutes of Health (NIH) have leveraged artificial intelligence to transform a device designed to see tissues in the back of the eye into one sharp enough to make out individual cells.
A new study show how the brain’s visual regions play an active role in making sense of information. Crucially, the way it interprets the information depends on what the rest of the brain is working on.
Research funded by the National Eye Institute offers insight into what is happening in our brains when our working memory must use its limited resources to remember multiple things.
Brown University researchers have identified a promising new approach that may help to restore vision in people affected by macular degeneration and other retinal disorders.
New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa. No therapy exists for this rare inherited disease, which starts affecting vision from childhood.
Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.